Novavax to deliver COVID vaccine to Japan in 2022

Novavax Inc. revealed on Friday the company will deliver the first supplies of its COVID-19 vaccine to Japan in late 2021 or during the first months of next year.

Japanese Takeda Pharmaceutical Co. is working with Novavax to ensure Japan receives around 250 million vaccine doses each year, while the deal is funded by Japan’s Health Ministry.

Novavax’s jab hasn’t been approved yet for emergency use, although the American company recently released a new study on its shot’s effectiveness versus new coronavirus strains. The vaccine is expected to be manufactured mostly in India’s Serum Institute.



Breaking the News / ND



Source link

About the author: admin Academy

admin

Alcuni articoli sono qui aggregati per darti un'informazione continua e costante, pertanto, sotto ognuno di essi troverai la fonte: entra nel sito di riferimento per avere ulteriori news ed informazioni sull'economia mondiale, ti sarà utile. Ti aspetto nell'Academy!

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento